Pregnancy-associated plasma protein a in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy - A prospective follow-up study

Diabetic Medicine

Volumn 24, Issue 12, 2007, Pages 1381-1385

  Astrup, A S ^a   Tarnow, L ^a   Christiansen, M ^b   Hansen, P R ^c   Parving, H H ^d,e   Rossing, P ^a  

^a STENO DIABETES CENTER   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

Author keywords

All cause mortality; Cardiovascular risk factor; Diabetic nephropathy; PAPP A; Type 1 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ACUTE CORONARY SYNDROME; ADULT; AGED; ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY;

ADULT; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A;

EID: 36549048318     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02283.x     Document Type: Article

References (27)

1. Ross R. Atherosclerosis - an inflammatory disease. N Eng J Med 1999 340 : 115 126.
2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001 104 : 365 372.
3. Loftus IM, Naylor AR, Bell PR, Thompson MM. Matrix metalloproteinases and atherosclerotic plaque instability. Br J Surg 2002 89 : 680 694.
4. Lawrence JB, Oxvig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Hays LG. et al. The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 1999 96 : 3149 3153.
5. Bayes-Genis A, Conover CA, Overgaard MT, Bailey KR, Christiansen M, Holmes DR Jr et al. Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Eng J Med 2001 345 : 1022 1029.
6. Cosin-Sales J, Christiansen M, Kaminski P, Oxvig C, Overgaard MT, Cole D et al. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Circulation 2004 109 : 1724 1728.
7. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985 28 : 590 596.
8. Astrup AS, Tarnow L, Rossing P, Pietraszek L, Hansen PR, Parving HH. Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study. Kidney Int 2005 68 : 1250 1257.
9. Parving H-H, Andersen AR, Smidt UM, Svendsen PA. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983 i : 1175 1179.
10. Tarnow L, Rossing P, Jacobsen P, Nielsen FS, Cambien F, Lecerf L. et al. Progression of diabetic nephropathy and the insertion/deletion polymorphism (ACE/ID) of the angiotensin-I-converting enzyme (ACE) gene. J Am Soc Nephrology 1995 6 : 457.
11. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L. et al. Lack of relationship between an insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995 44 : 489 494.
12. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 2003 362 : 759 766.
13. Feldt-Rasmussen B, Dinesen B, Deckert M. Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy. Scand J Clin Lab Invest 1985 45 : 539 544.
14. Bröchner-Mortensen J, Rödbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest 1976 36 : 35 45.
15. Hilsted J, Jensen SB. A simple test for autonomic neuropathy in juvenile diabetics. Acta Med Scand 1979 205 : 385 387.
16. Christiansen M, Jaliashvili I, Overgaard MT, Ensinger C, Obrist P, Oxvig C. Quantification and characterization of pregnancy-associated complexes of angiotensinogen and the proform of eosinophil major basic protein in serum and amniotic fluid. Clin Chem 2000 46 : 1099 1105.
17. Astrup AS, Tarnow L, Rossing P, Hansen BV, Hilsted J, Parving HH. Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care 2006 29 : 334 339.
18. Lund J, Qin QP, Ilva T, Nikus K, Eskola M, Porela P et al. Pregnancy-associated plasma protein A: a biomarker in acute ST-elevation myocardial infarction (STEMI). Ann Med 2006 38 : 221 228.
19. Heeschen C, Dimmeler S, Hamm CW, Fichtscherer S, Simoons ML, Zeiher AM. Pregancy-associated plasma protein A levels in patients with acute coronary syndromes - comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 2005 45 : 229 237.
20. Lund J, Qin QP, Ilva T, Pettersson K, Voipio-Pulkki LM, Porela P et al. Circulating pregnancy-associated plasma protein A predicts outcome in patients with acute coronary syndrome but no troponin I elevation. Circulation 2003 108 : 1924 1926.
21. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Eng J Med 1999 340 : 14 22.
22. Aso Y, Okumura K, Wakabayashi S, Takebayashi K, Taki S, Inukai T. Elevated pregnancy-associated plasma protein-a in sera from type 2 diabetic patients with hypercholesterolemia: associations with carotid atherosclerosis and toe-brachial index. J Clin Endocrinol Metab 2004 89 : 5713 5717.
23. Stulc T, Malbohan I, Malik J, Fialova L, Soukupova J, Ceska R. Increased levels of pregnancy-associated plasma protein A in patients with hypercholesterolemia: the effect of atorvastatin treatment. Am Heart J 2003 146 : E21.
24. Lauzurica R, Pastor C, Bayes B, Hernandez JM, Romero R. Pre-transplant pregnancy-associated plasma protein A as a predictor of chronic allograft nephropathy and post-transplant cardiovascular events. Transplantation 2005 80 : 1441 1446.
25. Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation 2006 114 : 1591 1598.
26. Folsom AR, Chambless LE, Ballantyne CM, Coresh J, Heiss G, Wu KK et al. An assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities study. Arch Intern Med 2006 166 : 1368 1373.
27. Lloyd-Jones DM, Liu K, Tian L, Greenland P. Narrative review: assessment of C-reactive protein in risk prediction for cardiovascular disease. Ann Intern Med 2006 145 : 35 42.